Multiple sclerosis: the EU turns to artificial intelligence for increasingly predictive and personalised therapies

Using artificial intelligence (AI) to process a sufficiently large amount of data and build a harmonised database , with the goal of making the clinical management of multiple sclerosis more predictive and tailored to each patient , ultimately improving quality of life and preserving autonomy. This is the work underway within the observational, retrospective study RECLAIM , conducted by researchers from several European partner institutions. The study integrates real-world healthcare data...

icometrix collaborates with AstraZeneca and MENACTRIMS on new AI-driven initiative aiming to improve NMOSD diagnosis across the Middle East & Africa

AI-powered MRI analysis expected to enhance early detection of NMOSD, reducing dependency on subjective visual interpretation Multi-country initiative using the MENACTRIMS registry to generate real‐world insights from 300 patients across 16 clinical sites Collaboration aims to shorten the average 2–4 year diagnostic delay and reduce the high rates of misdiagnosis commonly seen between NMOSD and Multiple Sclerosis DUBAI, UAE – ( ARAB NEWSWIRE ) AstraZeneca today announced a strategic regional...

Embedding imaging AI in your Alzheimer’s clinical workflow: From diagnosis to ARIA monitoring

The field of Alzheimer’s disease care is evolving rapidly . The approval of disease-modifying therapies have necessitated earlier...

GE HealthCare's Acquisition of icometrix: A Leap Towards Enhanced Neurological Care

Strengthening Neurological Solutions The anticipated acquisition aligns with GE HealthCare’s precision care strategy. The goal is to strengthen the company’s portfolio of offerings in neurological care and enhance its quantitative analysis of brain MRI. icometrix’s icobrain platform offers a comprehensive set of solutions for neurological disease analysis. This includes icobrain aria, the first AI Computer-Aided Detection and Diagnosis FDA 510(k) cleared solution. It detects known side...

icobrain receives ACR Transparent AI badge: advancing trusted AI in neuroimaging

We are proud to announce that icobrain has been awarded the ACR Transparent AI badge by the American College of Radiology (ACR). This...

A Shared Language for ARIA: Standardizing Alzheimer’s Imaging in the Age of New Therapies with RSNA

With the arrival of disease-modifying therapies for Alzheimer’s disease, we are entering a new era in neurodegenerative care. But with...

InRAD and icometrix partner to improve the standardization of care and real-world evidence generation in Alzheimer’s disease

Leuven, Belgium – June 9th, 2025 Attending  EAN 2025 in Helsinki  and want to learn more about this collaboration or the icobrain...

icometrix selected for MedTech Innovator’s 2025 Accelerator Mid-Stage Program

icometrix has been named to the prestigious 2025 MedTech Innovator Mid-Stage Accelerator cohort —an honor reserved for the top 4% of...

AI Ethics in Healthcare: Doing it Right

Wim Van Hecke - founder/CEO icometrix Artificial intelligence in healthcare is often portrayed as the counterpart of the human touch....

Revolutionizing Brain Imaging Through AI

Brain imaging has long been central to diagnosing neurological disease. Recent advances in artificial intelligence (AI) are transforming how clinicians interpret MRI data, offering earlier detection, objective quantification, and stronger support for clinical decision-making. AI-powered quantitative MRI, such as icometrix’s icobrain, enables automated, reproducible insights into brain structure and pathology, helping radiologists and neurologists detect subtle abnormalities, track disease...

icometrix rebranded: Same mission, sharper focus, scaled impact

Wim Van Hecke founder/CEO icometrix 16 May 2025 With a great team, we worked on refreshing the icometrix branding. It was a wonderful...

Only at Rush: Smarter MS Care With AI Insights and a Personal Companion App

A new partnership is giving Rush patients more insights and information on their MRI scans than ever before, making it easier to...

American College of Radiology (ACR) and icometrix collaborate to improve the quality of care for people with Alzheimer’s disease

Virginia, VA – April 2nd, 2025 The American College of Radiology (ACR), the professional medical society dedicated to advancing radiology...

Streamlining Medical Workflows Through Data Integration

In today’s healthcare environment, accuracy and efficiency are crucial. Clinicians face increasing demands to deliver high-quality care while managing vast amounts of patient and imaging data. Integrated medical systems, such as icometrix’s icobrain platform, connect imaging data, electronic health records (EHR), and clinical information into a seamless workflow, improving patient outcomes while reducing administrative burden and operational complexity. Integrated medical systems in a...

DENT Neurologic Institute partners with icometrix to advance Alzheimer’s care

January 13, 2025  Buffalo, NY On November 7th 2024, the U.S. Food and Drug Administration (FDA) granted ico metrix clearance for ico...

Philips and icometrix Announce Strategic Partnership

A medical professional analyzes brain scans enhanced by artificial intelligence, highlighting advancements in neurological imaging...

The first AI-driven MRI solution for safer Alzheimer’s treatment

On November 7th, 2024, the U.S. Food and Drug Administration (FDA) granted icometrix clearance for icobrain aria , the first and only AI...

icometrix Named Finalist for Scale-Up of the Year 2024 Award

LEUVEN, Belgium - October 17th 2024 ico metrix is honored to be named one of four finalists for the prestigious Flemish Government’s...

Baptist Health First In Arkansas To Utilize Cutting-Edge icometrix AI Technology for Neuroradiology

LITTLE ROCK, Ark.   – October 10th 2024  - Baptist Health is the first health care organization in Arkansas to utilize ico metrix ’s...

SEQSTER and icometrix Announce Groundbreaking Partnership to Advance Neurological Care

Longitudinal Real-World Data combined with AI-Powered Imaging to Enhance Detection and Management of Neurological Disorders, Accelerating...

Market approval for icobrain aria

icometrix is proud to announce the market approval of icobrain aria , the first market-approved solution for monitoring amyloid-related...

From rigorous validation to reimbursement

A new CPT-III code for brain MRI quantification  Since the AMA issued CPT-III codes 0865T/0866T, which are applicable to brain MRI...

Groundbreaking clinical validation of icobrain aria

In a landmark achievement for Alzheimer's disease treatment, icometrix unveils the groundbreaking clinical validation of icobrain aria ...

How to use CPT® codes (0865T and 0866T) for quantitative brain MRI

The American Medical Association (AMA) and the American College of Radiology (ACR) have published an article demonstrating how to use the...

RSNA 2023: Unveiling icometrix' AI-Driven Neuroimaging Revolution for Optimal Patient Care

Nov 22, 2023 The culmination of the year’s radiology events, the RSNA conference in Chicago presents an opportune moment for...

icobrain aria: a breakthrough in Alzheimer’s disease management and care

Today, 32 million people are suffering from Alzheimer’s disease globally, and it is reported that more than 400 million people are on the...

Progress(ion) in Multiple Sclerosis

(and what we can learn from the field of multiple sclerosis to optimize data-driven care in Alzheimer's disease) It is that time of the...

Unlocking the Future of Alzheimer's Care

Sep 21, 2023 Insights from leading clinicians on digital health technologies in 2023 2023 has been an exciting year for developments in...

One step closer to integrating magnetic resonance spectroscopy and multimodal imaging in medicine

It is the official end of INSPiRE-MED, a European training network funded by the European Union's Horizon 2020 research and innovation...

AMA issues CPT® III code for icometrix’ AI-related brain MRI quantification software

New CPT® III code enables tracking and reimbursement pathway for AI-supported brain MRI (e.g., icometrix) BOSTON, USA / LEUVEN, BELGIUM —...

Advancing Precision Medicine through Big Data and Digital Technology

Jun 27, 2023 Revolutionizing Neurology: Advancing Precision Medicine through Big Data and Digital Technology The utilization of clinical...

Advancing Precision Medicine through Big Data and Digital Technology

Jun 27, 2023 Revolutionizing Neurology: Advancing Precision Medicine through Big Data and Digital Technology The utilization of clinical...

Europe’s IHI awards prestigious grant CLAIMS

Europe’s Innovative Health Initiative awards prestigious grant “CLAIMS”, enabling precision medicine for MS patients  Brussels, 22nd of...

icometrix awarded a grant by The Michael J. Fox Foundation to research brain MRI biomarkers for Parkinson’s disease

ico metrix (Leuven, Belgium | Boston, MA, USA) - March 17, 2023 - ico metrix , world leader in imaging artificial intelligence (AI)...

Compliance with the GDPR regulations

Mar 16, 2023 The need for data privacy and security As cloud computing becomes more and more integrated in medical decision making,...

icometrix receives NIHR AI in Health and Care Award

London - March 3, 2023   —  ico metrix  & Queen Mary University of London receive prestigious AI Award from the National Institute for...

Compliance with HIPAA regulations

Jan 5, 2023 Data privacy and security – How icometrix ensures compliance with the HIPAA regulation The need for data privacy and security...

DocPanel opts for icobrain portfolio

Leuven, Belgium/ Chicago, US - June 8, 2022  —  ico metrix announced today that DocPanel has selected the ico brain portfolio to...

Visit of HRH Princess Astrid of Belgium in the framework of the economic mission to the USA

Leuven, Belgium | Boston, US - May 20, 2022. Ahead of the economic mission to the United States of America, from June 4 to June 12 led by...

May 12th - International Nurses Day - Insights from our Poll at the BVNV Conference

May 12th, is International Nurses Day! When talking to patients, we always hear how much they value their nurses! They are always there...

icometrix’s MRI measures for PwMS receive MIB from NICE

ico metrix , the worldwide leader in digital health technology solutions for neurological conditions, announced the recent release of a...

Diagnostic performance of automated MRI volumetry for Alzheimer’s disease

https://chernolya.wixstudio.com/icometrix-new/disease/dementia-and-alzheimer Jul 2, 2021 This study examines the diagnostic value of ico...

icometrix and Aidoc team up to transform stroke care coordination

Leuven, Belgium | Boston, US - June 22, 2021 - Today, ico metrix , the world leader in imaging AI solutions for people with neurological...

icometrix selected as new partner in EHDEN project

Leuven, Belgium | Boston, US - January 21, 2021 -  On December 16th, 2021 ico metrix was selected as a new data partner in the European...

Volumetric MRI quantification in the diagnosis of Alzheimer's disease

Apr 7, 2021 A definite diagnosis of Alzheimer’s disease (AD) can only be confirmed on an autopsy examination of brain tissue. However,...

Role of volumetric software in the extended treatment window of acute ischemic stroke

Feb 23, 2021 In 2018, two randomized controlled trials, DEFUSE 31and DAWN2 showed the benefit of mechanical thrombectomy in patients with...

icometrix and Upcare Partners & Associates partnership to scale up icobrain and icompanion in the Canadian healthcare market

Leuven, Belgium |Boston, US - February 8, 2021 - ico metrix announced today that the Toronto-based UpCare Partners & Associates has been...

Digital healthin multiple sclerosis care

The need for personalized medicine in multiple sclerosis Research in multiple sclerosis (MS) treatments has brought tremendous progress....

icometrix Joins Nuance AI Marketplace for Diagnostic Imaging

Leuven, Belgium / Boston, US - January 25, 2021 - ico​ metrix ​today announced that its ico ​brain software portfolio will be available...

Lake Medical Imaging integrates icobrain for use in clinical practice

Leuven, Belgium / Boston, US – January 21, 2021 - ico metrix announced today that Lake Medical Imaging has selected the ico brain...

icometrix wins EIT Digital Challenge 2020 for Digital Wellbeing

LEUVEN, Belgium, and CHICAGO, IL, USA - November 16, 2020 – ico metrix , a world leader in (imaging) AI solutions for people with brain...

Health economic valueof brain atrophy and lesion monitoringin MS management

Sep 14, 2020 How improved monitoring can reduce loss of QALY and health economical costs Multiple Sclerosis (MS) is a chronic...

The role of imaging AI and CT in COVID-19

Apr 28, 2020 This post aims to elucidate the clinical role of ico lung , the first CE marked AI software for the quantification of thorax...

Brain imaging in MS, 3 steps to optimize your MRI protocol

Feb 5, 2020 The ultimate goal of medical imaging is to acquire more meaningful data in less time. Finding a good tradeoff between...

icometrix and Guerbet sign an agreement

Guerbet signs an agreement with icometrix for the exclusive distribution of icobrain, an artificial intelligence medical imaging solution...

Atrophy in MS: How icometrix ensures accurate brain volumetric analysis

May 19, 2020 The value of brain atrophy in outcome prediction and treatment monitoring for multiple sclerosis (MS) is undisputed....

Brain imaging AI leader icometrix raises $18 million in new funding

Company’s technology will transform care for patients with brain disorders and injuries May 14th, 2019 – Leuven/Geneva/Boston ico metrix...

Lesion characterization in traumatic brain injury using Machine Learning

Feb 28, 2019 Article courtesy of AI BLOG, ESR Traumatic Brain Injury (TBI) is a complex neurological condition that requires fast...

Invicro and icometrix Announce a Unique Partnership.

(Boston, MA and Leuven, Belgium) February 25, 2019 – Invicro LLC, a Konica Minolta company and ico metrix jointly announced a...

icometrix partners with Siemens Healthineers to help patients with brain disorders with artificial intelligence

LEUVEN, Belgium, and CHICAGO, IL, USA - February 25th, 2019 – ico metrix , the world leader in software solutions using artificial...

Affidea and icometrix, a partnership towards better patient care in Europe

LEUVEN, Belgium, and CHICAGO, IL, USA - February 21st, 2019 - Today, Affidea and ico metrix announce a strategic partnership, with the...

AI is a means,not a goal

Oct 31, 2019 Article courtesy of AI BLOG, ESR Artificial intelligence (AI) software solutions developed for radiology are increasingly...

Leading MS center Vall d’Hebron, Barcelona to advance neuroradiological practice with icobrain AI portfolio

Leuven, Belgium and Chicago, IL, USA, August 9th 2018 - ico metrix , the world leader in software solutions to obtain clinically...

icometrix announces collaboration with Japanese Micron to position itself for additional growth in Asia

icometrix N.V. and Micron Inc. recently signed a collaboration agreement for the distribution of ico brain to the Japanese market. The...

Why brain atrophy measurements matter

Mar 2, 2017 In Multiple Sclerosis (MS), irreversible neurological impairment is being caused by inflammation and neurodegenerative...